In glioma, TUG1 functions as a tumor suppressor by promoting cell apoptosis via activating caspase-3 and caspase-9 mediated intrinsic pathways and inhibiting Bcl-2 mediated anti-apoptotic pathways (Li et al., 2016). The gene discussed is BCL2; the disease is neoplasm.